Today’s patients are no longer passive but rather engaged, active participants in their health and wellness even before seeking treatment by a healthcare practitioner. They interact using social media, converse within web-based patient communities and utilize mobile technologies to help them monitor, diagnose and manage illness. Acknowledging this empowerment, the life sciences industry is moving "beyond the pill" to focus on patient-centered solutions; enhancing the patient experience by proving therapeutic value, resolving barriers to treatment access, designing adherence programs and offering physicians, healthcare systems and pharmacists solutions to improve effectiveness and enhance patient care. By examining each stage of commercialization through the patient's eyes, aligning with the treatment decision journey and delivering the right mix of services at the right time using the right communication channel, health outcomes can markedly improve.
Enter Signals Analytics, creators of the only cloud-based analytical intelligence platform that transforms the world's unconnected data into actionable insights to enhance therapeutic outcomes, optimize product portfolio health and propel patient-centered innovation. By utilizing our revolutionary Decision Science as a Service platform, commercialization executives can uncover a holistic view of patient populations, develop targeted programs based on stakeholder roles, and connect these offerings to drive superior omnichannel experiences.
“Within 3 weeks Signals Playbook identified the top acquisition targets across 10 categories, some of whom we were unaware even existed. We immediately moved to due diligence with 16 of them and saved months in the process.”
– Head of New Ventures at a Top 5 Consumer Healthcare Company
Signals Impact to Your Business
Assure Product Launch Activities are Congruent with all Stages of the Patient Treatment Journey
Build, Monitor and Enhance Outcomes-Focused Patient Access and Support Strategies
Uncover Technology Partnerships for Digital "Beyond the Pill" Value Creation
Increase Adherence and Minimize Substitutions Through Digital Health Ecosystem Management
Improve Omnichannel Patient and Provider Experience to Drive Peak Revenue
A Top 20 Global Life Sciences Company Renovates
a Prominent Drug Portfolio
A leading global pharmaceutical company aimed to close a $200M revenue gap following the acquisition of a new consumer health products portfolio. Within weeks, Signals Playbook modeled global patient populations and their therapeutic needs with 92% greater accuracy than conventional methods, and the company immediately commenced renovation of its global go-to-market strategies.
The Signals Difference
Precision Intelligence That Matters Most to Your Enterprise
Real Time Signals Detection with Validated Source Data
Built By Industry Experts For Industry Experts
Rapid Business Impact and Value Right Out of the Box
Machine Learning Combined with Human Intelligence
The Latest From Signals
1325 Avenue of the Americas, 25th Floor
New York, NY 10019
(917) 470 9110
7 Giborei Israel St.
P.O.B 8374, Netanya 4250407, Israel
+972 73 718 1650